Two federal inmates have pleaded guilty to stealing nearly $138,000 from the Bureau of Prisons by establishing a fraudulent company and billing the government for nonexistent products.
The maker of a highly touted experimental Alzheimer's vaccine has ended development of the compound after 15 patients suffered serious brain inflammation.
Sprint Corp. on Friday announced it had obtained a $1 billion loan commitment and hired investment firms for advice on what its directory publishing business may be worth in a sale.